The post The Bitwise Chainlink ETF Secures NYSE Listing Greenlight appeared on BitcoinEthereumNews.com. Key Insights: NYSE Arca issues regulatory clearance to BitwiseThe post The Bitwise Chainlink ETF Secures NYSE Listing Greenlight appeared on BitcoinEthereumNews.com. Key Insights: NYSE Arca issues regulatory clearance to Bitwise

The Bitwise Chainlink ETF Secures NYSE Listing Greenlight

Key Insights:

  • NYSE Arca issues regulatory clearance to Bitwise’s Chainlink ETF, paving the way for more institutional flows.
  • Chainlink’s growing role in predictive markets and institutional-grade data for the RWA markets.
  • LINK crypto’s slow grind underscores potential pivot in larger time frames.

Last year, the spot ETF segment got quite heated, and 2026 is shaping up to be even more exciting. Spot Chainlink ETF is building up momentum courtesy of the latest approval.

The NYSE Arca just gave listing approval to Bitwise’s spot Chainlink (LINK) ETF. This makes it the latest spot ETF to be listed on the NYSE, where it is scheduled to commence trading on Thursday.

Bitwise Chainlink ETF Secures NYSE Listing | Source: CryptosRus, X

The Bitwise Chainlink ETF is the second spot ETF for the LINK coin after Grayscale’s ETF which was approved in December 2025. This latest approval highlights growing institutional exposure.

Chainlink has been establishing itself as a key infrastructure for the blockchain industry. This is one of the key reasons for its institutional appeal. More Chainlink ETF filings are expected in the coming months.

Bitwise’s Chainlink ETF push has been leaning heavily on the network’s strategic positioning. During a recent interview, Ryan Rasmussen, the head of research and asset management director at Bitwise, described Chainlink as a critical infrastructure for predictive markets.

Bitwise Head of Research on Chainlink Critical Role | Source: Chainlink, X

His statement underscored Chainlink’s essential role in the market in facilitating access to data in WEB3.  The network has been striking key partnerships aimed at ensuring data accessibility.

One of those partnerships was with GMTrade, which aims to provide institutional-grade data for the RWAs where high data integrity is critical. This also means Chainlink is positioning itself to take advantage of the growth opportunities in the rapidly-growing RWAs segment.

This positioning could be the key reason why demand for exposure to Chainlink has been rising. The big question now is whether this will be a setup for Chainlink’s native coin LINK to be one of the best-performing cryptocurrencies in 2026.

LINK price pushed as high as $14.20 in the last 24 hours after rallying over 7%. However, the cryptocurrency remained stuck within its short-term bottom range, where it has been stuck for the last few months.

Chainlink (LINK) price has been stuck within the bottom range since mid-November. However, its weekly chart signals that it may be gradually building momentum in favor of a bullish recovery, after previously maintaining a steep downtrend since August last year.

LINK Price Action | Source: TradingView

Interestingly, LINK’s RSI just crossed above its RSI-based MA for the first time since mid-September. The last time such a crossing occurred after a sizable downtrend was in June, after which LINK price rallied by more than 100%.

These observations suggest that Chainlink price could be on the cusp of a recovery rally. However, that would require a healthy demand wave to push for a solid recovery.

LINK spot flow data revealed that sell pressure has been cooling. However, inflows remained weak, hence the lack of a significant recovery. Large order book data also revealed limited demand from the whale cohort.

Meanwhile, on the derivatives segment, open interest recovered slightly from a 4-week low of $507 million to $672 million at the time of observation. This signaled that derivatives investors were building up confidence, albeit gradually.

Chainlink Open Interest | Source: CoinGlass

The recent Chainlink ETF approval for listing on the NYSE could be the trigger that brings back attention to LINK. The crypto could be on the verge of a solid recovery in the next few weeks if market conditions allow.

Source: https://www.thecoinrepublic.com/2026/01/14/the-bitwise-chainlink-etf-secures-nyse-listing-greenlight/

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0,00222
$0,00222$0,00222
-%4,68
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26